RISK FACTORS FOR IN-HOSPITAL MORTALITY AFTER SURGICAL TREATMENT OF INFECTIVE ENDOCARDITIS

Dr. Madhusudan Kummari, Dr Ramakrishna Tella, Dr Chaitra Bhat, Dr R. v. Kumar

Abstract


INTRODUCTION: To study the clinical profile, effected heart valves and the organisms involved and prognostic factors in patients undergoing
surgery for infective endocarditis.
MATERIALS AND METHODS: All patients who were admitted and operated for infective endocarditis from 2011 through 2017 in single unit
of NIMS hospital were included in the study. The study protocol was approved by the Hospital Ethics committee.
RESULTS: A total of 30 patients with infective endocarditis were operated between 2011through 2017. 22 males and 8 females,mean age was
36.7.Out of 30 patients 29(96%) of the patients had native valve endocarditis (NVE) and only 1 patient had prosthetic valve endocarditis
(PVE).The Mitral valve was involve in 12 (40%), Aortic valve 10 (33%) and both valves were effected in 6 patients. The most common indications
for surgery were refractory heart failure and persistent infection, 9 and 5 respectively. Heart failure and sepsis were the major post-operative
complications. Elevated liver aminotransferases had significant association with in-hospital mortality (p value AST-0.024; ALT-0.004). There
were 9 deaths during study period.
CONCLUSIONS: Surgery for infective endocarditis still carries a high mortality rate. Elevated liver aminotransferases are helpful in predicting
mortality rates.


Full Text:

PDF

References


Bin Abdulhak AA,Baddour LM, Erwinz PJ, Hoenx B, Chujj VH,Mensah GA. Global and Regional Burden of Infective Endocarditis, 1990-2010.A Systematic Review of the Literature. Global Heart; 9(1) March 2014: 131-143.

Kouchoukos NT, Blackstone BH, Hanley FL, Kirklin JK. Cardiac Surgery. Morphology, Diagnostic Criteria, Natural History, Techniques, Results, and Indications. Fourth EditionS. A. Geller. Infective endocarditis: a history of the development of its understanding. Autopsy and Case Reports 2013; 3(4): 5-12.

Grinberg M, Solimene MC. Historical aspects of infective endocarditis. Rev Assoc Med Bras 2011; 57(2):223-228.

Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A et al. Trends in Infective Endocarditis Incidence, Microbiology, and Valve Replacement in the United States From 2000 to 2011. Journal ofThe American College of Cardiology; 65 (19), 2015:2070–6.

Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992–2001. International Journal of Cardiology 98 (2005) 253– 260.

Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J. 2015 Nov 21; 36(44):3075-3128.

Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr, Tleyjeh IM, Rybak MB et al. Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications. A Scientific Statement for Healthcare Professionals from the American Heart Association. Circulation. 2015; 132:1435-1486.

Wallace SM, Walton BI, Kharbanda RK, Hardy R, Wilson AP, Swanton RH. Mortality from infective endocarditis: clinical predictors of outcome. Heart 2002; 88: 53–60.

Bedeir K, Reardon M, Ramlawi B. Infective endocarditis: Perioperative management and surgical principles.J Thorac Cardiovasc Surg 2014; 147: 1133-41.

Butchart EG, Gohlke-Ba¨rwolf C, Antunes MJ, Tornos P, De Caterina R, Cormier R et al. Recommendations for the management of patients after heart valve surgery. European Heart Journal (2005) 26, 2463–2471.

Gammie JS, O’Brien SM, Griffith BP, Peterson ED. Surgical Treatment of Mitral Valve Endocarditis in North America. Ann ThoracSurg 2005; 80: 2199 –204.

Yankah AC, Pasic M, Klose H, Siniawski H, Weng H, Hetzer R. Homograft reconstruction of the aortic root for endocarditis with periannular abscess: a 17-year study. European Journal of Cardio-thoracic Surgery 28 (2005) 69–75.

Farag M, Borst T, Sabashnikov A, Zeriouh M, Schmack B, Arif R et al. Surgery for Infective Endocarditis: Outcomes and Predictors of Mortality in 360 Consecutive Patients. Med SciMonit, 2017; 23: 3617-3626

Vlessis AA, Hovaguimian H, Jaggers J, Ahmad A, Starr A. Infective Endocarditis: Ten-Year Review of Medical and Surgical Therapy. Ann Thorac Surg 1996; 61: 1217-22.

Grubitzsch H, Schaefer A, Melzer C, Wernecke KD, Gabbieri D, Konertz W. Outcome after surgery for prosthetic valve endocarditis and the impact of preoperative treatment. J Thorac Cardiovasc Surg 2014; 148: 2052-9.

Matsuura R, Yoshioka D, Toda K, Yokoyama J, Miyagawa S, Yoshikawa Y et al. Effect of the Initial Strategy for Active Endocarditis Complicated With Acute Heart Failure. Circ J 2018; 82: 2896 – 2904.

Kothari SS, Ramakrishnan S, Bahl VK. Infective Endocarditis – An Indian Perspective. Indian Heart J 2005; 57: 289-294.

Abhilash KP, Patole S, Jambugulam M, Sathyendra S, Mitra S, Rebekah G, et al.. Changing Trends of Infective Endocarditis in India: A South Indian Experience. Journal of Cardiovascular Disease Research. 2017; 8(2):56-60.

Gupta A, Gupta A, Kaul U, Varma A. Infective endocarditis in an Indian setup: Are we entering the ‘modern’ era? Indian J Crit Care Med. 2013 May-Jun; 17(3): 140–147.

Math RS, Sharma G, Kothari SS, Kalaivani M, Saxena A, Sampath Kumar A et al. Prospective study of infective endocarditis from a developing country. Am Heart J 2011; 162: 633-8.

Choudhury R, Grover A, Varma J, Khattri HN, Anand IS, Bidwai PS et al..Active infective endocarditis observed in an Indian hospital 1981-1991.Am J Cardiol. 1992 Dec 1; 70(18):1453-8.

Murdoch DR, Corey GR, Hoen B, et al. Clinical Presentation, Etiology, and Outcome of Infective Endocarditis in the 21st Century: The International Collaboration on Endocarditis–Prospective Cohort Study. Arch Intern Med. 2009; 169(5):463–473.

Baumgartner H. Infective endocarditis in adults with congenital heart disease: is it time to change our approach to prophylaxis based on new insights into risk prediction? Eur Heart J. 2011 Aug; 32(15):1835-7.

Rushani D, Kaufman JS, Ionescu-Ittu R, Mackie AS, Pilote L, Therrien J et al. Infective endocarditis in children with congenital heart disease: cumulative incidence and predictors. Circulation 2013 Sep 24; 128(13):1412-9.

Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, Veen G et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J. 2011 Aug; 32(15):1926-34.

Yuan SM. Mycobacterial endocarditis: a comprehensive review. Braz J Cardiovasc Surg 2015; 30(1):93-103.

Strabelli TM, Siciliano RF, Castelli JB, Demarchi LM, Leão SC, Viana-Niero C et al.. Mycobacterium chelonae valve endocarditis resulting from contaminated biological prostheses. J Infect. 2010 Jun; 60(6):467-73.

Hadjinikolaou L, Triposkiadis F, Zairis M, Chlapoutakis E, Spyrou P. Successful management of Brucella mellitensis endocarditis with combined medical and surgical approach. Eur J Cardiothorac Surg. 2001 Jun; 19(6):806-10.

Raju IT, Solanki R, Patnaik AN, Barik RC, Kumari NR, Gulati AS. Brucella endocarditis - a series of five case reports. Indian Heart J. 2013 Jan-Feb; 65(1):72-7.

Sia T, Podin Y, Chuah T-B, Wong J-S. Melioidosis: an unusual cause of infective endocarditis: a case report. European Heart Journal - Case Reports (2018) 2, 1–4.

Currie BJ, Ward L, Cheng AC.The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoSNegl Trop Dis. 2010 Nov 30; 4(11):e900.

Piyasiri L B, Wickramasinghe S A, Lekamvasam V C, Corea E M, Gunarathne R, Priyadarshana U. Endocarditis in melioidosis. Ceylon Med J. 2016 Dec 30; 61(4):192-193.

Netzer RO, Altwegg SC, Zollinger E, Täuber M, Carrel T, Seiler C. Infective endocarditis: determinants of long term outcome. Heart. 2002 Jul; 88(1):61-6.

Røder BL, Wandall DA, Frimodt-Møller N, Espersen F, Skinhøj P, Rosdahl VT. Clinical features of Staphylococcus aureus endocarditis: a 10-year experience in Denmark. Arch Intern Med. 1999 Mar 8; 159(5):462-9.

López J1, Sevilla T, Vilacosta I, Sarriá C, Revilla A, Ortiz C et al. Prognostic role of persistent positive blood cultures after initiation of antibiotic therapy in left-sided infective endocarditis. Eur Heart J. 2013 Jun; 34(23):1749-54.

Thuny F, Beurtheret S, Mancini J, Gariboldi V, Casalta JP, Riberi A et al. The timing of surgery influences mortality and morbidity in adults with severe complicated infective endocarditis: a propensity analysis. Eur Heart J. 2011 Aug; 32(16):2027-33.

Liang F, Song B, Liu R, Yang L, Tang H, Li Y. Optimal timing for early surgery in infective endocarditis: a meta-analysis. Interact Cardiovasc Thorac Surg. 2016 Mar; 22(3):336-45.

Hill EE, Herijgers P, Herregods MC, Peetermans WE. Evolving trends in infective endocarditis. ClinMicrobiol Infect. 2006 Jan; 12(1):5-12.

Delay D, Pellerin M, Carrier M, Marchand R, Auger P, Perrault LP et al. Immediate and long-term results of valve replacement for native and prosthetic valve endocarditis. Ann Thorac Surg. 2000 Oct; 70(4):1219-23.

Jassal DS, Neilan TG, Pradhan AD, Lynch KE, Vlahakes G, Agnihotri AK et al. Surgical management of infective endocarditis: early predictors of short-term morbidity and mortality. Ann Thorac Surg. 2006 Aug; 82(2):524-9.

Mestres CA, Castro MA, Bernabeu E, Josa M, Cartaná R, Pomar JL et al. Preoperative risk stratification in infective endocarditis. Does the EuroSCORE model work? Preliminary results.Eur J Cardiothorac Surg. 2007 Aug; 32(2):281-5.

Mokhles MM, Ciampichetti I, Head SJ, Takkenberg JJ, Bogers AJ. Survival of surgically treated infective endocarditis: a comparison with the general Dutch population. Ann Thorac Surg. 2011 May; 91(5):1407-12.


Refbacks

  • There are currently no refbacks.